ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Triphenylphosphine → 1-(azetidin-1-yl)-2-(2-fluoro-4-{2-[(1S,2R)-2-{1-[5-(methoxymethyl)pyridin-2-yl]piperidin-4-yl}cyclopropyl]ethoxy}phenyl)ethanone

HRID 1474738
ノート
印刷プレビュー

反応式

HRID 1474738 の反応式
CC(OC(/N=N/C(OC(C)C)=O)=O)C.[N:15]1([C:19](=[O:29])[CH2:20][C:21]2[CH:26]=[CH:25][C:24]([OH:27])=[CH:23][C:22]=2[F:28])[CH2:18][CH2:17][CH2:16]1.[CH3:30][O:31][CH2:32][C:33]1[CH:34]=[CH:35][C:36]([N:39]2[CH2:44][CH2:43][CH:42]([C@H:45]3[CH2:47][C@H:46]3[CH2:48][CH2:49]O)[CH2:41][CH2:40]2)=[N:37][CH:38]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>C1(C)C=CC=CC=1>[N:15]1([C:19](=[O:29])[CH2:20][C:21]2[CH:26]=[CH:25][C:24]([O:27][CH2:49][CH2:48][C@@H:46]3[CH2:47][C@@H:45]3[CH:42]3[CH2:43][CH2:44][N:39]([C:36]4[CH:35]=[CH:34][C:33]([CH2:32][O:31][CH3:30])=[CH:38][N:37]=4)[CH2:40][CH2:41]3)=[CH:23][C:22]=2[F:28])[CH2:18][CH2:17][CH2:16]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 11776TriphenylphosphineHCID 5363146Diisopropyl azodicarboxylateHCID 89582175HCID 89582175、化合物HCID 895841062-[(1S,2R)-2-{1-[5-(methoxymethyl)pyridin-2-yl]piperidin-4-yl}cyclopropyl]ethanol

生成物 1

HCID 895839431-(azetidin-1-yl)-2-(2-fluoro-4-{2-[(1S,2R)-2-{1-[5-(methoxymethyl)pyridin-2-yl]piperidin-4-yl}cyclopropyl]ethoxy}phenyl)ethanone

試薬・触媒・溶媒 1

HCID 1140Toluene溶媒

実験手順

DIAD (38.2 μl, 0.196 mmol) was added to a stirred mixture of 1-(azetidin-1-yl)-2-(2-fluoro-4-hydroxyphenyl)ethanone (41.1 mg, 0.196 mmol), 2-[(1S,2R)-2-{1-[5-(methoxymethyl)pyridin-2-yl]piperidin-4-yl}cyclopropyl]ethanol (57 mg, 0.196 mmol), and triphenyl phosphine (51.5 mg, 0.196 mmol) in toluene (327 μl). The mixture was degassed (3×) and stirred at RT for 2 hours. The mixture was diluted with ethyl acetate (20 mL), washed with water (20 ml), the layers separated, the aqueous phase extracted with EtOAc (20 ml), the organic fractions combined, washed with brine (35 ml), dried over sodium sulfate, filtered and the volatiles removed in vac. The residue was purified by column chromatography on silica gel, Biotage 25 g, using a gradient eluant of 0-100% EtOAc/hexanes to afford the title compound. LC/MS (m/z): 482 (M+H)+. GPR119 Human EC50: 0.94 nM

後処理

  1. customThe mixture was degassed (3×)
  2. additionThe mixture was diluted with ethyl acetate (20 mL)
  3. washwashed with water (20 ml)
  4. customthe layers separated
  5. extractionthe aqueous phase extracted with EtOAc (20 ml)
  6. washwashed with brine (35 ml)
  7. dry with materialdried over sodium sulfate
  8. filtrationfiltered
  9. customthe volatiles removed in vac
  10. customThe residue was purified by column chromatography on silica gel, Biotage 25 g

出典と根拠

ORDレコード
ord-37760c8a2a6c48ef995b2a3092a0c91a
出典データセット
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09018224B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート